Tau, Diabetes and Insulin

6Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Tau protein which was discovered in 1975 [310] became of great interest when it was identified as the main component of neurofibrillary tangles (NFT), a pathological feature in the brain of patients with Alzheimer’s disease (AD) [39, 110, 232]. Tau protein is expressed mainly in the brain as six isoforms generated by alternative splicing [46, 97]. Tau is a microtubule associated proteins (MAPs) and plays a role in microtubules assembly and stability, as well as diverse cellular processes such as cell morphogenesis, cell division, and intracellular trafficking [49]. Additionally, Tau is involved in much larger neuronal functions particularly at the level of synapses and nuclei [11, 133, 280]. Tau is also physiologically released by neurons [233] even if the natural function of extracellular Tau remains to be uncovered (see other chapters of the present book).

Cite

CITATION STYLE

APA

Gratuze, M., Joly-Amado, A., Buee, L., Vieau, D., & Blum, D. (2019). Tau, Diabetes and Insulin. In Advances in Experimental Medicine and Biology (Vol. 1184, pp. 259–287). Springer. https://doi.org/10.1007/978-981-32-9358-8_21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free